肝硬化患者血清促甲状腺激素和甲状腺素水平变化及其临床意义*

doi:10.3969/j.issn.1672-5069.2017.06.034

Abstract

Tulson, Han Dan, Zhang Yuexin. Correlation analysis of serum TSH、FT3、FT4 levels with liver function damage degree of cirrhosis patients Corbinuel[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(6): 764-765.

References

[1] 丁红兵,陈育霞,杨环文,等. 自身免疫性肝炎与原发性胆汁性肝硬化患者血生化和肝组织病理学分析. 实用肝脏病杂志,2014,17（1）:84-85.
[2] Mitsuzaki K,Yamashita Y,Ogata I,et al. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis:contrast-injection protocol and optimal timing. Am J Roentgenol,2013,167（3）:753-757.
[3] Dehghani SM,Haghighat M,Eghbali F,et al. Thyroid hormone levels in children with liver cirrhosis awaiting a liver transplant. Exp Clin Transplant,2013,11（2）:150-153.
[4] 黄新次,余福安. 血清甲状腺激素在肝硬化患者肝储备功能判断及预后评估中的价值分析. 中华医院感染学杂志,2012,22（20）:4495-4497.
[5] 顾薇,滕春雨. 肝硬化患者血清甲状腺激素水平变化的临床意义. 中国中西医结合消化杂志,2016,12（4）:319-323.
[6] El-Eshmawy MM,Arafa MM,Elzehery RR,et al. Relationship between vitamin A deficiency and the thyroid axis in clinically stable patients with liver cirrhosis related to hepatitis C virus. Applied Physiology,2016,41（9）:1-7.
[7] 中华医学会肝病学分会. 慢性乙型肝炎诊断标准（2015年版）. 中西医结合肝病杂志,2015,25（6）:384-384.
[8] 中国中西医结合学会消化系统疾病专业委员会. 肝硬化中西医结合诊疗共识. 中国中西医结合消化杂志,2011,19（4）:277-279.
[9] Mazzaferri EL. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med,2013,14（10）:549-553.
[10] Bergh J J,Lin HY,Lansing L,et al. Integrin ɑ V β 3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology,2013,146（7）:2864-2871.
[11] Penteado KR,Coelho JC,Parolin MB,et al. The influence of end-stage liver disease and liver transplantation on thyroid hormones. Arq Gastroenterol,2015,52（2）:124-128.
[12] 陈海英. 血清甲状腺激素水平对慢性肝硬化患者治疗疗效影响研究. 海南医学院学报,2013,19（1）:47-49.
[13] 郄会卿,刘翠清,王春秀. 肝硬化患者肝纤维化与血清甲状腺激素水平关系研究. 现代预防医学,2012,39（20）:5368-5369.
[14] 肖海刚,单艳,祁从辉,等. 肝硬化失代偿期并发甲状腺功能减退的临床分析. 中国临床医学,2011,18（5）:638-640.
[15] Atalay R,Ersoy R,Demirezer AB,et al. Day-night variations in thyroid stimulating hormone and its relation with clinical status and metabolic parameters in patients with cirrhosis of the liver. Endocrine,2015,48（3）:942-948.
[16] Torun E,Ozgen IT,Gokce S,et al. Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease. J Clin Res Pediatr Endocrinol,2014,6（1）:34-39.
[17] 张东艳,梁茱. 肝硬化患者血清甲状腺素水平的变化及其临床意义. 海南医学,2012,23（17）:92-93.
[18] 李坤,沈天白,李莹. 慢性乙型肝炎和乙型肝炎肝硬化患者血清铁蛋白的变化. 实用肝脏病杂志,2015,18（6）:620-623.
[19] Wagener G. Assessment of hepatic function,operative candidacy,and medical management after liver resection in the patient with underlying liver disease.Semin Liver Dis,2013,33（3）:204-212.
[20] 赵春华,周志强,任光学,等. 肝硬化z肝脏肋单元数与肝功能Child-Pugh分级的关系. 中国临床医学影像杂志,2015,26（10）:708-711.

Correlation analysis of serum TSH、FT3、FT4 levels with liver function damage degree of cirrhosis patients Corbinuel

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[3]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[4]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[5]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[6]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[7]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.
[8]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[9]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[10]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.
[11]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[12]	Jin Lianghong, Li Xingjie, Guan Hongbo, et al. Clinical value of dual-energy CT iodine quantification combined with dynamic contrast-enhanced MRI in evaluating hepatic hemodynamics and liver functions in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 712-715.
[13]	Bian Xinqu, Chen Jie, Liu Yanmin, et al. Serum thyroid hormone level changes in patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy [J]. Journal of Practical Hepatology, 2019, 22(5): 716-719.
[14]	Xiao Han, Wang Li. Mechanisms of thrombocytopenia in liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 462-465.
[15]	Han Meiling, Chen Ping. Antiviral therapy in patients with liver cirrhosis and thrombocytopenia [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 466-469.